Trump and Xi’s fierce phone battle leaves rare earth crisis boiling, while U.S. manufacturers face a terrifying summer of uncertainty.
Trump-Xi Call Fails to Halt Escalating U.S. Rare Earth Crisis Ahead of Critical Summer
The Latest
Is AI the Left’s New Weapon? J.D. Vance Labels It a Communist Tool
New data exposes AI’s hidden political agenda: 96% of language models favor the left. Is artificial intelligence a communist threat?
Microsoft Challenges AI Industry Norms With Bold New Safety Ranking for Models
Microsoft forces AI companies to prove their models aren’t toxic with a groundbreaking safety rating system. Will the industry survive this radical shift?
XRP Crashes 34%—Is This the Smartest Time to Buy or a Risky Trap?
XRP plunges 34% while institutional whales quietly load up. Is this a golden chance or a dangerous trap? Smart money already knows.
Will IonQ’s Radical Quantum Bet Pay Off for Long-Term Investors?
IonQ’s quantum gamble could revolutionize computing or drain billions. AstraZeneca success hints at glory, but fierce competition threatens their future.
Why Wells Fargo Backs These 2 Stocks as the Dow Climbs—Even Amid Uncertainty
Despite market uncertainty, Wells Fargo bets big on two stocks as their massive $40B buyback program shakes up Wall Street strategies.
Why the Proposed $40,000 SALT Cap Could Make High-Income Taxpayers Even Richer
The rich get richer: How a $320 billion SALT cap change could widen America’s wealth gap while middle-class families watch.
Why Buffett Puts Nearly $130 Billion Into Just 3 Dividend Stocks—And Won’t Budge
While others chase risky trends, Warren Buffett quietly poured $130 billion into three “boring” dividend stocks. His strategy defies Wall Street logic.
Why $500 in These 2 Underrated Dividend Stocks Could Outperform Flashier Growth Picks
While tech stocks grab headlines, these two underappreciated dividend titans quietly build wealth with 5%+ yields. Your portfolio might thank you later.
Wall Street Sees These Growth Stocks Skyrocketing Up to 116%—But Are They Too Good to Be True?
Wall Street predicts massive gains for growth stocks, but the 116% upside forecast might be a dangerous siren song. Should investors trust the hype?